Preclinical evaluation of WYE-687, a mTOR kinase inhibitor, as a potential anti-acute myeloid leukemia agent

Biochemical and Biophysical Research Communications
Feng ChengMize Lu

Abstract

Mammalian target of rapamycin (mTOR) as a potential drug target for treatment of acute myeloid leukemia (AML). Here, we investigated the potential anti-leukemic activity by WYE-687, a potent mTOR kinase inhibitor. We demonstrated that WYE-687 potently inhibited survival and proliferation of established (HL-60, U937, AML-193 and THP-1 lines) and human AML progenitor cells. Yet, same WYE-687 treatment was non-cytotoxic to the primary peripheral blood mononuclear leukocytes (PBMCs) isolated from healthy donors. WYE-687 induced caspase-dependent apoptotic death in above AML cells/progenitor cells. On the other hand, the pan-caspase inhibitor (Z-VAD-FMK), the caspase-3 specific inhibitor (Z-DEVD-FMK) or the caspase-9 specific inhibitor (z-LEHD-fmk) attenuated WYE-687-induced cytotoxicity. At the molecular level, WYE-687 concurrently inhibited activation of mTORC1 (p70S6K1 and S6 phosphorylations) and mTORC2 (AKT Ser-473 and FoxO1/3a phosphorylations), whiling downregulating mTORC1/2-regulated genes (Bcl-xL and hypoxia-inducible factor 1/2α) in both HL-60/U937 cells and human AML progenitor cells. In vivo, oral administration of WYE-687 potently inhibited U937 leukemic xenograft tumor growth in severe combined immunodeficient (SCID) ...Continue Reading

References

Nov 20, 2004·Blood·Christian RécherBernard Payrastre
Aug 18, 2006·Nature Reviews. Cancer·David M Sabatini
Oct 3, 2009·The Lancet Oncology·Brian I Rini, Michael B Atkins
Dec 3, 2009·Haematologica·Sophie ParkDidier Bouscary
Mar 18, 2010·Nature Reviews. Clinical Oncology·Janet Dancey
Jan 11, 2011·Molecular Cancer Therapeutics·Eduardo VilarJosep Tabernero
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 24, 2012·Hematology/oncology Clinics of North America·Alejandro Gomez-Pinillos, Anna C Ferrari
Dec 7, 2013·Biochemical and Biophysical Research Communications·Hai-zhong HuoYan Gu
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 22, 2014·Nature Reviews. Molecular Cell Biology·Mitsugu Shimobayashi, Michael N Hall
Apr 1, 2015·Biochemical and Biophysical Research Communications·Li YangWen-Fang Zhuang
May 21, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shang-Jun Jiang, Shuo Wang

❮ Previous
Next ❯

Citations

Sep 16, 2016·Journal of Drug Targeting·Azam Roohi, Mohammad Hojjat-Farsangi
Feb 12, 2020·Molecular Medicine·Deze ZhaoHelei Hou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Shang-Jun Jiang, Shuo Wang
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Jian HuangJie Jin
© 2022 Meta ULC. All rights reserved